Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRV.
Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRV.
复制标题
DOI:
10.1021/ct9004678
复制
发表时间:
2010-04-13
影响因子:
5.5
通讯作者:
Schiffer, Celia A.
中科院分区:
文献类型:
--
作者:
Cai, Yufeng;Schiffer, Celia A.
Darunavir (DRV) is a high affinity (4.5×10-12 M, ΔG = -15.2 kcal/mol) HIV-1 protease inhibitor. Two drug-resistant protease variants FLAP+ (L10I, G48V, I54V, V82A) and ACT (V82T, I84V) decrease the binding affinity with DRV by 1.0 kcal/mol and 1.6 kcal/mol respectively. In this study the absolute and relative binding free energies of DRV with wild-type protease, FLAP+ and ACT were calculated with MM-PB/GBSA and thermodynamic integration methods, respectively. Free energy decomposition elucidated that the mutations conferred resistance by distorting the active site of HIV-1 protease so that the residues that lost binding free energy were not limited to the sites of mutation. Specifically the bis-tetrahydrofuranylurethane moiety of DRV maintained interactions with the FLAP+ and ACT variants, whereas the 4 – amino phenyl group lost more binding free energy with the protease in the FLAP+ and ACT complexes than in the wild-type protease which could account for the majority of the loss in binding free energy. This suggested that replacement of the 4 – amino phenyl group might generate new inhibitors less susceptible to the drug resistant mutations.
登录
查看更多内容
影响因子:
3
作者:
Gohlke, H;Case, DA
通讯作者:
Case, DA
影响因子:
56.9
作者:
BASH, PA;SINGH, UC;KOLLMAN, PA
通讯作者:
KOLLMAN, PA
影响因子:
5.6
作者:
Archontis, G;Simonson, T;Karplus, M
通讯作者:
Karplus, M
影响因子:
3
作者:
Duan, Y;Wu, C;Kollman, P
通讯作者:
Kollman, P
影响因子:
5.6
作者:
Archontis, G;Simonson, T;Karplus, M
通讯作者:
Karplus, M